×
Hero Background

Diabetes Pen Companies

ID: MRFR/MED/0146-HCR
105 Pages
Rahul Gotadki
October 2025

The market for diabetes pens involves several multinational pharmaceutical and medical device companies that manufacture insulin pens for diabetes management. These companies operate globally, including in the Americas.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

ReportInfographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Diabetes Pen Market

Americas Diabetes Pen Key Companies

 

Latest Americas Diabetes Pen Companies Update


Novo Nordisk price reduction: In March 2023, Novo Nordisk announced a 75% price reduction for vials and pens of NovoLog and other insulin brands in the United States. This move is expected to increase the adoption of insulin pens, particularly among cost-conscious consumers.


Cequr's new insulin pen: In June 2022, Cequr launched its Insulin Pen 2.0TM, which features advanced features like automated insulin delivery, real-time glucose monitoring, and personalized dosing recommendations. This pen is expected to be a game-changer in the market for smart insulin pens.


List of Americas Diabetes Pen Key Companies in the Market



  • Becton, Dickinson And Company

  • Novo Nordisk A/S

  • Ypsomed Holding Ag

  • Owen Mumford, Ltd.

  • Sanofi

  • Eli Lilly

  • Merck Animal Health